These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2876592)

  • 1. Increased inosinate dehydrogenase activity in mycophenolic acid resistant neuroblastoma cells.
    Hodges SD; Fung E; Lin CC; Snyder FF
    Adv Exp Med Biol; 1986; 195 Pt B():271-4. PubMed ID: 2876592
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells.
    Hodges SD; Fung E; McKay DJ; Renaux BS; Snyder FF
    J Biol Chem; 1989 Oct; 264(30):18137-41. PubMed ID: 2572589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mutant murine lymphoma cells with altered inosinate dehydrogenase activities.
    Ullman B
    J Biol Chem; 1983 Jan; 258(1):523-8. PubMed ID: 6129253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagen-induced resistance to mycophenolic acid in hamster cells can be associated with increased inosine 5'-phosphate dehydrogenase activity.
    Huberman E; McKeown CK; Friedman J
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3151-4. PubMed ID: 6114490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic properties of IMP dehydrogenase purified from rat hepatoma 3924A.
    Yamada Y; Ikegami T; Natsumeda Y; Weber G
    Adv Exp Med Biol; 1989; 253B():51-5. PubMed ID: 2575351
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular characterization of IMP dehydrogenase in acquired resistance to mycophenolic acid.
    Snyder FF; Lightfoot T; Hodges SD
    Adv Exp Med Biol; 1994; 370():725-8. PubMed ID: 7661007
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of IMP dehydrogenase in differentiating HL-60 cells.
    Collart FR; Huberman E
    Blood; 1990 Feb; 75(3):570-6. PubMed ID: 1967537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP dehydrogenase mutants: cell culture model for hyperuricemia.
    Ullman B
    Adv Exp Med Biol; 1984; 165 Pt A():373-9. PubMed ID: 6144250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in purine excretion and rate of synthesis by drugs inhibiting IMP dehydrogenase or adenylosuccinate synthetase activities.
    Willis RC; Seegmiller JE
    Adv Exp Med Biol; 1979; 122B():237-41. PubMed ID: 44644
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the IMP dehydrogenase gene in Chinese hamster cells resistant to mycophenolic acid.
    Collart FR; Huberman E
    Mol Cell Biol; 1987 Sep; 7(9):3328-31. PubMed ID: 2890098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
    Hedstrom L; Wang CC
    Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct target sites on IMP dehydrogenase in chemotherapy.
    Yamada Y; Natsumeda Y; Yamaji Y; Weber G
    Adv Exp Med Biol; 1989; 253B():57-63. PubMed ID: 2575352
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of inosinate dehydrogenase.
    Kuttan R; Saunders P
    Biochem Int; 1987 Feb; 14(2):211-8. PubMed ID: 2883976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and characterization of mycophenolic acid-resistant leukemia cells.
    Cohen MB
    Somat Cell Mol Genet; 1987 Nov; 13(6):627-33. PubMed ID: 2890214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMP dehydrogenase, an enzyme linked with proliferation and malignancy.
    Jackson RC; Weber G; Morris HP
    Nature; 1975 Jul; 256(5515):331-3. PubMed ID: 167289
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
    Page JD; Chaney SG; Hall IH; Lee KH; Holbrook DJ
    Biochim Biophys Acta; 1987 Nov; 926(2):186-94. PubMed ID: 2889474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inosine 5'-monophosphate dehydrogenase from sarcoma 180 cells-substrate and inhibitor specificity.
    Miller RL; Adamczyk DL
    Biochem Pharmacol; 1976 Apr; 25(8):883-8. PubMed ID: 944580
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on inosine monophosphate dehydrogenase. Steady state kinetics.
    Heyde E; Nagabhushanam A; Vonarx M; Morrison JF
    Biochim Biophys Acta; 1976 May; 429(3):645-60. PubMed ID: 178371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for the rapid determination of the stereospecificity of NAD-dependent dehydrogenases applied to mammalian IMP dehydrogenase and bacterial NADH peroxidase.
    Cooney D; Hamel E; Cohen M; Kang GJ; Dalal M; Marquez V
    Biochim Biophys Acta; 1987 Nov; 916(1):89-93. PubMed ID: 2889473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.